Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from PfizerBioNTech

Updated COVID mRNA Vaccines Get FDA Approval: Here's What To Know

The updated COVID shots from Pfizer-BioNTech and Moderna target the current KP.2 strain of SARS-CoV-2, a descendant of the highly contagious Omicron subvariant JN.1.

Medical Daily

Poor countries face vaccine inequity

Vaccination is a global strategy, yet many low-income countries can't access then, perpetuating the pandemic

Salon

mRNA technology beat COVID-19, can it do the same for pancreatic cancer?

Half the pancreatic cancer patients in a new clinical trial were alive and cancer free after 18 months. Most usually die within three months.

The New Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

China approves first domestic mRNA vaccine for Covid-19

Beijing (AFP) - China has approved its first locally developed messenger RNA (mRNA) vaccine against Covid-19, its manufacturer said Wednesday, months after the relaxation of strict Covid-zero regulations sparked a surge in cases.

AFP

Moderna, Pfizer and BioNTech Covid vaccine patent dispute heads to 2024 trial

US firm Moderna is suing its competitors for alleged patent infringement in relation to their Comirnaty vaccine.

The Independent UK

Bivalent COVID vaccines have now been in use for a few months – here's how they're stacking up against omicron

Vaccines have played a major role in mitigating the harms of the COVID pandemic since their rollout began just over two years ago. They’re estimated to have saved tens of millions of lives around the globe.

The Conversation

Getting vaccinated this holiday season? Here’s how to stay up-to-date on your COVID shots

DALLAS — Staying on schedule with the COVID-19 vaccine can feel like chasing a moving target.

Tribune News Service

Read news from The Economist, FT, and more,
with one subscription

EU watchdog backs Sanofi Covid booster jab

The Hague (AFP) - The EU on Thursday approved a Covid booster vaccine by French drug maker Sanofi and Britain's GSK after it gave positive results against the Omicron variant in trials.

AFP

African scientists say Western aid to fight pandemic is backfiring. Here's their plan

Monkeypox is the latest case of how global health inequities persist. Vaccines went to the rich world while Africa lacks access. African scientists call for a bold plan to protect against pathogens.

WEKU

Fla. surgeon general's anti-vax warning

"This study is too flawed to be used to set policy on the mRNA vaccines in younger males," one expert said

Salon

How the new bivalent Covid vaccines work

Paris (AFP) - France became the latest country on Tuesday to authorise new Covid-19 vaccines that have been updated to target Omicron subvariants ahead of autumn booster campaign.

AFP

Covid-19 boosters: Immunologists answer 5 key questions about the new shots

What is different about the updated booster shots? Two scientists offer their expertise to answer five questions about the shots.

Inverse

When will Omicron boosters be available? Who is eligible for Covid jab and how to book

The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has approved a second Coronavirus booster vaccine to target the Omicron variant ahead of the autumn booster programme

Daily Mirror

Pfizer/BioNTech Covid-19 booster approved by UK medicines regulator

The vaccine targets both the original strain of coronavirus and the Omicron variant.

The Independent UK

Get all your
news in one place.

100’s of premium titles.
One news app.

The Conversation

Will omicron-specific booster shots be more effective at combating COVID-19? 5 questions answered

On Sept. 1, 2022, the Centers for Disease Control and Prevention endorsed the use of updated COVID-19 booster shots that are specifically tailored to combat the two most prevalent omicron subvariants, BA.4 and BA.5. The decision comes just a day after the Food and Drug Administration’s emergency use authorization of…

Reason

FDA Approves Updated COVID-19 Booster Shots

But does everyone really need to get boosted?

AFP

US approves shots targeting Omicron

Washington (AFP) - US officials Wednesday authorized updated Covid-19 vaccinations by Moderna and Pfizer-BioNTech that specifically target the latest strains of the Omicron variant, hoping to contain a new wave of feared contagions this winter.

AFP

US approves updated Pfizer, Moderna shots targeting Omicron

Washington (AFP) - US health officials on Wednesday authorized updated Covid-19 vaccinations by Moderna and Pfizer-BioNTech that specifically target the latest strains of the Omicron variant, with the goal of jump-starting a new booster campaign.

Get all your
news in one place.

100’s of premium titles.
One news app.

Asharq Al-Awsat

Moderna Sues Pfizer/BioNTech for Patent Infringement over COVID Vaccine

Moderna sued Pfizer and its German partner BioNTech on Friday for patent infringement in the development of the first COVID-19 vaccine approved in the United States, alleging they copied technology that Moderna developed years before the pandemic. Pfizer shares fell nearly 1%, while BioNTech US-listed shares were down about 1.5%…

The Independent UK

Moderna sues Pfizer and BioNTech over Covid-19 vaccine

The vaccine maker said it had filed patent infringement lawsuits in the US and Germany.

Evening Standard

Moderna sues Pfizer/BioNTech alleging patent infringement over Covid vaccine

Moderna seeks unspecified damages in lawsuit over rivals’ jab

Bangkok Post

Moderna sues Pfizer over Covid vaccine

Moderna is suing Pfizer and its German partner BioNTech for patent infringement in the development of the first Covid-19 vaccine approved in the United States, alleging they copied technology that Moderna developed years before the pandemic.

Tribune News Service

Boost now or wait? Many wonder how best to ride out COVID's next wave

Gwyneth Paige didn’t want to get vaccinated against COVID-19 at first. With her health issues — hypertension, fibromyalgia, asthma — she wanted to see how other people fared after the shots. Then her mother got colon cancer.

Chicago Sun-Times

Get fourth COVID booster now, or wait? CDC says get the shot now, but many hesitate

About 70% of Americans 50 and older who got a first booster shot — and nearly as many of those 65 and older — haven’t gotten their second booster dose, the CDC says.

The Conversation

Should you get a COVID-19 booster shot now or wait until fall? Two immunologists help weigh the options

While COVID-19 vaccines continue to be highly effective at preventing hospitalization and death, it has become clear that the protection offered by the current vaccines wanes over time. This necessitates the use of booster shots that are safe and effective in enhancing the immune response against the virus and extending…

1 2

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

330 stories

GSK

316 stories

Centers for Disease Control and Prevention

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.